Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses
- PMID: 20100088
- DOI: 10.1086/650464
Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses
Abstract
Background: The viral fitness of neuraminidase inhibitor (NAI)-resistant influenza viruses is believed to be impaired. Unexpectedly, an oseltamivir-resistant A(H1N1) variant containing the H274Y neuraminidase (NA) mutation recently disseminated worldwide, suggesting that the replication and virulence properties of this mutant virus were not compromised.
Methods: In vitro replicative capacities were determined for old (A/WSN/33, A/Mississipi/3/01, A/New Caledonia/20/99, and A/Solomon Islands/03/06) and recent (A/Brisbane/59/2007-like) influenza A(H1N1) viruses either harboring or not harboring the H274Y NA mutation. Ferrets were infected with the A/Brisbane/59/2007-like wild-type (WT) isolate and its H274Y NA variant.
Results: Old A(H1N1) WT viruses grew at higher titers than did the A/Brisbane/59/2007-like viruses in vitro. The H274Y mutation was associated with reduced viral plaque areas in cells infected with A/WSN/33 and A/Mississippi/3/01, whereas the 2 A/Brisbane/59/2007-like isolates showed similar plaque sizes. In ferrets, the pyrexic response induced by the A/Brisbane/59/2007-like H274Y mutant was significantly higher than that induced by the WT isolate. Nasal wash viral titers were significantly greater for the mutant isolate on day 2 after inoculation, whereas the 2 viruses showed similar titers between days 3 and 7 after inoculation.
Conclusions: The viral fitness of the recent A/Brisbane/59/2007-like H274Y variant is not impaired, consistent with its global dissemination. These results reinforce the need for new antiviral strategies.
Comment in
-
Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses.J Infect Dis. 2010 Mar;201(5):656-8. doi: 10.1086/650465. J Infect Dis. 2010. PMID: 20100087 No abstract available.
Similar articles
-
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3. J Clin Virol. 2010. PMID: 19962344
-
Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.J Infect Dis. 2004 Nov 1;190(9):1627-30. doi: 10.1086/424572. Epub 2004 Sep 28. J Infect Dis. 2004. PMID: 15478068
-
Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.Antiviral Res. 2009 Apr;82(1):29-33. doi: 10.1016/j.antiviral.2009.01.004. Epub 2009 Jan 31. Antiviral Res. 2009. PMID: 19428592
-
[Drug-resistant influenza viruses: an overview].Nihon Rinsho. 2010 Sep;68(9):1671-8. Nihon Rinsho. 2010. PMID: 20845746 Review. Japanese.
-
Influenza virus susceptibility and resistance to oseltamivir.Antivir Ther. 2007;12(4 Pt B):603-16. Antivir Ther. 2007. PMID: 17944268 Review.
Cited by
-
Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1(Suppl 1):50-7. doi: 10.1111/irv.12044. Influenza Other Respir Viruses. 2013. PMID: 23279897 Free PMC article. Review.
-
XIth International Symposium on Respiratory Viral Infections.Influenza Other Respir Viruses. 2011 Nov;5(6):443-52, e455-7. doi: 10.1111/j.1750-2659.2011.00255.x. Epub 2011 Apr 29. Influenza Other Respir Viruses. 2011. PMID: 21668671 Free PMC article.
-
Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.Antimicrob Agents Chemother. 2014 Sep;58(9):5220-8. doi: 10.1128/AAC.03313-14. Epub 2014 Jun 23. Antimicrob Agents Chemother. 2014. PMID: 24957832 Free PMC article.
-
Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines.Cell Discov. 2023 Jun 16;9(1):58. doi: 10.1038/s41421-023-00571-x. Cell Discov. 2023. PMID: 37328456 Free PMC article. Review.
-
Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.Viruses. 2021 Apr 6;13(4):624. doi: 10.3390/v13040624. Viruses. 2021. PMID: 33917376 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources